Concepts (114)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Drug Carriers | 2 | 2020 | 709 | 0.900 |
Why?
|
Nanoparticles | 4 | 2023 | 1985 | 0.750 |
Why?
|
Metal Nanoparticles | 2 | 2023 | 406 | 0.730 |
Why?
|
Chemoembolization, Therapeutic | 2 | 2023 | 128 | 0.690 |
Why?
|
Liver Neoplasms, Experimental | 1 | 2020 | 189 | 0.670 |
Why?
|
Carcinoma, Hepatocellular | 4 | 2023 | 2333 | 0.670 |
Why?
|
Pentose Phosphate Pathway | 1 | 2019 | 126 | 0.620 |
Why?
|
Carbon Isotopes | 1 | 2019 | 458 | 0.600 |
Why?
|
Gold | 2 | 2023 | 488 | 0.570 |
Why?
|
Docosahexaenoic Acids | 2 | 2020 | 914 | 0.550 |
Why?
|
Copper Radioisotopes | 3 | 2019 | 100 | 0.550 |
Why?
|
Perylene | 2 | 2013 | 22 | 0.520 |
Why?
|
Stilbenes | 2 | 2016 | 155 | 0.520 |
Why?
|
Liver Neoplasms | 4 | 2023 | 4362 | 0.490 |
Why?
|
Phototherapy | 1 | 2015 | 368 | 0.390 |
Why?
|
Iodine Radioisotopes | 2 | 2013 | 1034 | 0.390 |
Why?
|
Fibrosarcoma | 1 | 2013 | 313 | 0.360 |
Why?
|
Infusions, Intra-Arterial | 2 | 2020 | 220 | 0.350 |
Why?
|
Doxorubicin | 1 | 2016 | 2234 | 0.330 |
Why?
|
Glioblastoma | 1 | 2023 | 3464 | 0.300 |
Why?
|
Lipoproteins, LDL | 2 | 2020 | 644 | 0.280 |
Why?
|
Glucose | 1 | 2019 | 4352 | 0.280 |
Why?
|
Radiopharmaceuticals | 3 | 2016 | 2735 | 0.270 |
Why?
|
Carcinoma, Pancreatic Ductal | 1 | 2016 | 1757 | 0.240 |
Why?
|
Positron-Emission Tomography | 3 | 2019 | 6669 | 0.210 |
Why?
|
Cell Line, Tumor | 6 | 2023 | 17140 | 0.190 |
Why?
|
Brain Neoplasms | 1 | 2023 | 9118 | 0.190 |
Why?
|
Liver | 4 | 2023 | 7577 | 0.190 |
Why?
|
Antineoplastic Agents | 3 | 2013 | 13676 | 0.180 |
Why?
|
Molecular Targeted Therapy | 1 | 2012 | 2830 | 0.170 |
Why?
|
Tissue Distribution | 2 | 2020 | 2300 | 0.170 |
Why?
|
Hepatic Artery | 1 | 2020 | 232 | 0.160 |
Why?
|
Animals | 16 | 2023 | 169246 | 0.160 |
Why?
|
Adenocarcinoma | 1 | 2016 | 6395 | 0.150 |
Why?
|
Catheters, Indwelling | 1 | 2020 | 436 | 0.140 |
Why?
|
Ethiodized Oil | 1 | 2016 | 26 | 0.140 |
Why?
|
Blood-Brain Barrier | 1 | 2023 | 1034 | 0.140 |
Why?
|
Nanospheres | 1 | 2016 | 21 | 0.140 |
Why?
|
Rats, Sprague-Dawley | 2 | 2019 | 8128 | 0.130 |
Why?
|
Thermography | 1 | 2016 | 62 | 0.130 |
Why?
|
Anthracenes | 2 | 2013 | 83 | 0.130 |
Why?
|
Paclitaxel | 1 | 2023 | 1733 | 0.130 |
Why?
|
Hyperthermia, Induced | 2 | 2016 | 416 | 0.130 |
Why?
|
Rats | 4 | 2023 | 23760 | 0.120 |
Why?
|
Glycolysis | 1 | 2019 | 837 | 0.120 |
Why?
|
Hep G2 Cells | 1 | 2015 | 378 | 0.110 |
Why?
|
Tubulin Modulators | 1 | 2012 | 106 | 0.100 |
Why?
|
Drug Delivery Systems | 1 | 2023 | 2232 | 0.100 |
Why?
|
Mice | 8 | 2023 | 82029 | 0.100 |
Why?
|
Rhabdomyosarcoma | 2 | 2012 | 358 | 0.100 |
Why?
|
Histocytochemistry | 1 | 2013 | 699 | 0.100 |
Why?
|
Signal Processing, Computer-Assisted | 1 | 2019 | 1489 | 0.100 |
Why?
|
Random Allocation | 1 | 2016 | 2396 | 0.100 |
Why?
|
Radionuclide Imaging | 2 | 2013 | 2000 | 0.090 |
Why?
|
Metformin | 1 | 2019 | 909 | 0.090 |
Why?
|
Polyethylene Glycols | 1 | 2016 | 1196 | 0.090 |
Why?
|
Neoadjuvant Therapy | 1 | 2022 | 2907 | 0.090 |
Why?
|
Ultrasonography | 4 | 2023 | 6004 | 0.080 |
Why?
|
Mice, Nude | 3 | 2022 | 3623 | 0.080 |
Why?
|
Dose-Response Relationship, Drug | 1 | 2020 | 10760 | 0.080 |
Why?
|
Disease Models, Animal | 3 | 2022 | 18349 | 0.070 |
Why?
|
Mice, SCID | 1 | 2013 | 2627 | 0.070 |
Why?
|
Imidazoles | 1 | 2012 | 1169 | 0.070 |
Why?
|
Small Molecule Libraries | 1 | 2012 | 742 | 0.070 |
Why?
|
Mice, Inbred BALB C | 1 | 2015 | 6231 | 0.070 |
Why?
|
Myocardium | 1 | 2019 | 4788 | 0.060 |
Why?
|
HEK293 Cells | 1 | 2015 | 4283 | 0.060 |
Why?
|
Breast Neoplasms | 2 | 2022 | 21206 | 0.060 |
Why?
|
Transplantation, Heterologous | 1 | 2013 | 2393 | 0.060 |
Why?
|
Indoles | 1 | 2012 | 1836 | 0.060 |
Why?
|
RNA, Messenger | 1 | 2019 | 12800 | 0.060 |
Why?
|
Kidney | 1 | 2019 | 7064 | 0.050 |
Why?
|
Neoplasms | 1 | 2012 | 22371 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 4 | 2023 | 36743 | 0.050 |
Why?
|
Humans | 12 | 2023 | 768166 | 0.050 |
Why?
|
Radiography | 1 | 2013 | 6983 | 0.050 |
Why?
|
Pyridines | 1 | 2012 | 2894 | 0.040 |
Why?
|
Male | 5 | 2020 | 364719 | 0.040 |
Why?
|
Survival Analysis | 1 | 2013 | 10101 | 0.040 |
Why?
|
Ovarian Neoplasms | 1 | 2016 | 4916 | 0.040 |
Why?
|
Liver Function Tests | 1 | 2020 | 526 | 0.040 |
Why?
|
Octreotide | 1 | 2019 | 156 | 0.040 |
Why?
|
Protons | 1 | 2023 | 1113 | 0.040 |
Why?
|
Kidney Function Tests | 1 | 2020 | 684 | 0.040 |
Why?
|
Treatment Outcome | 4 | 2023 | 65371 | 0.040 |
Why?
|
Receptors, Peptide | 1 | 2019 | 280 | 0.040 |
Why?
|
Female | 6 | 2023 | 397192 | 0.030 |
Why?
|
Injections, Intravenous | 1 | 2019 | 1377 | 0.030 |
Why?
|
Rats, Wistar | 1 | 2020 | 1888 | 0.030 |
Why?
|
Biological Transport | 1 | 2019 | 2085 | 0.030 |
Why?
|
Copper | 1 | 2016 | 368 | 0.030 |
Why?
|
Tomography, Emission-Computed, Single-Photon | 1 | 2019 | 1140 | 0.030 |
Why?
|
Microsomes, Liver | 1 | 2012 | 174 | 0.030 |
Why?
|
Polymerization | 1 | 2012 | 155 | 0.020 |
Why?
|
Caco-2 Cells | 1 | 2012 | 366 | 0.020 |
Why?
|
Brain | 1 | 2019 | 27360 | 0.020 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2012 | 297 | 0.020 |
Why?
|
Solubility | 1 | 2012 | 1083 | 0.020 |
Why?
|
Diffusion Magnetic Resonance Imaging | 1 | 2022 | 2815 | 0.020 |
Why?
|
Permeability | 1 | 2012 | 725 | 0.020 |
Why?
|
Drug Screening Assays, Antitumor | 1 | 2012 | 719 | 0.020 |
Why?
|
Contrast Media | 1 | 2023 | 5330 | 0.020 |
Why?
|
Tubulin | 1 | 2012 | 695 | 0.020 |
Why?
|
Lipids | 1 | 2020 | 3343 | 0.020 |
Why?
|
Signal Transduction | 1 | 2012 | 23645 | 0.020 |
Why?
|
Imaging, Three-Dimensional | 1 | 2022 | 4063 | 0.020 |
Why?
|
Mitosis | 1 | 2012 | 1178 | 0.020 |
Why?
|
Structure-Activity Relationship | 1 | 2012 | 3055 | 0.020 |
Why?
|
Longitudinal Studies | 1 | 2022 | 14783 | 0.020 |
Why?
|
Blood Glucose | 1 | 2020 | 6430 | 0.020 |
Why?
|
Reactive Oxygen Species | 1 | 2012 | 2149 | 0.010 |
Why?
|
Cell Cycle | 1 | 2012 | 2932 | 0.010 |
Why?
|
Drug Resistance, Neoplasm | 1 | 2012 | 5341 | 0.010 |
Why?
|
Cell Proliferation | 1 | 2012 | 10474 | 0.010 |
Why?
|
Concepts
(114)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(2)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_
Same Department
People in same department with this person.
Explore
_